Showing results (51-60 of 80) with videos related to
Sort By:
Pageof 8
Bioinformatics (Oxford, England)|July 10, 2018
Computational analysis of kinase inhibitor selectivity using structural knowledgeYu-Chen Lo, Tianyun Liu, Kari M Morrissey, et al.Bioorganic & Medicinal Chemistry Letters|April 2, 2014
Identification of tertiary sulfonamides as RORc inverse agonistsBenjamin P Fauber, Olivier René, Brenda Burton, et al.Bioorganic & Medicinal Chemistry Letters|September 1, 2015
Identification of N-sulfonyl-tetrahydroquinolines as RORc inverse agonistsBenjamin P Fauber, Alberto Gobbi, Pascal Savy, et al.Journal of the American Chemical Society|September 12, 2022
Sulfated Zirconium Metal-Organic Frameworks as Well-Defined Supports for Enhancing Organometallic CatalysisZoha H Syed, Mohammad Rasel Mian, Roshan Patel, et al.Inorganic Chemistry|June 7, 2011
Inorganic chemistry and IONiC: an online community bringing cutting-edge research into the classroomElizabeth R Jamieson, Hilary J Eppley, Margret J Geselbracht, et al.Bioorganic & Medicinal Chemistry Letters|August 16, 2016
Discovery of oxa-sultams as RORc inverse agonists showing reduced lipophilicity, improved selectivity and favorable ADME propertiesOlivier René, Benjamin P Fauber, Adrian Barnard, et al.Journal of Medicinal Chemistry|February 7, 2008
Quinazolinones and pyrido[3,4-d]pyrimidin-4-ones as orally active and specific matrix metalloproteinase-13 inhibitors for the treatment of osteoarthritisJie Jack Li, Joe Nahra, Adam R Johnson, et al.Nature Chemistry|July 24, 2025
Introducing metal-sulfur active sites in metal-organic frameworks via post-synthetic modification for hydrogenation catalysisHaomiao Xie, Milad Ahmadi Khoshooei, Mukunda Mandal, et al.Bioorganic & Medicinal Chemistry Letters|November 19, 2013
Structure-based design of substituted hexafluoroisopropanol-arylsulfonamides as modulators of RORcBenjamin P Fauber, Gladys de Leon Boenig, Brenda Burton, et al.Journal of Medicinal Chemistry|June 11, 2015
Discovery of 1-{4-[3-fluoro-4-((3s,6r)-3-methyl-1,1-dioxo-6-phenyl-[1,2]thiazinan-2-ylmethyl)-phenyl]-piperazin-1-yl}-ethanone (GNE-3500): a potent, selective, and orally bioavailable retinoic acid receptor-related orphan receptor C (RORc or RORγ) inverse agonistBenjamin P Fauber, Olivier René, Yuzhong Deng, et al.Pageof 8